Barclays »

Innate Pharma shares owned by Barclays

Quarter-by-quarter ownership of Innate Pharma (IPHA) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Innate Pharma

Tip: Access up to 7 years of quarterly data

All positions including Innate Pharma held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Innate Pharma by Barclays

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.0k 412 2.43
2023-09-30 $1.0k 412 2.43
2023-06-30 $1.0k 412 2.43
2023-03-31 $1.0k 412 2.43
2022-12-31 $2.0k 412 4.85
2022-09-30 $0 123 0.00
2022-06-30 $6.0k 2.2k 2.75
2022-03-31 $11k 3.4k 3.22